Research Peptide Compliance — United Kingdom
Wild Ginger Peptides supplies synthetic peptide compounds strictly for in-vitro laboratory research. This policy explains what that means in practice, what uses are permitted, what is prohibited, and how buyers should describe and handle our products.
All Wild Ginger Peptides products are strictly for in-vitro research and laboratory use only. They are not approved or intended for human consumption, veterinary administration, diagnostic purposes or any therapeutic application. Placing an order is an agreement to these terms.
Permitted research applications
Our research peptides — including BPC-157, TB-500, Semaglutide, Tirzepatide and Retatrutide — are supplied for the following types of work:
- In-vitro receptor-binding and signalling assays
- Cell-culture and biochemical pathway studies
- Analytical reference work (HPLC, mass spectrometry, structural confirmation)
- Preclinical animal-model research conducted under appropriate ethical and regulatory oversight
- Educational laboratory demonstration in qualified academic settings
Prohibited uses
The following uses fall outside what these compounds are supplied for, and are not authorised:
- Human consumption, injection, ingestion or topical application
- Veterinary, diagnostic or therapeutic use of any kind
- Resale or repackaging for human or veterinary supply
- Marketing, recommending or describing as a medicine, supplement or treatment
- Compounding or dispensing in any clinical or pharmacy setting
Regulatory status (UK)
The compounds listed in the Wild Ginger Peptides UK catalogue are research chemicals. They have not been evaluated or approved by the Medicines & Healthcare products Regulatory Agency (MHRA), the U.S. Food and Drug Administration (FDA), or any equivalent regulatory body for human or veterinary medicinal use.
These products are not classified as medicines, food supplements or cosmetics. They are supplied as analytical and research reagents, with each batch documented by an in-house Certificate of Analysis (CoA) confirming identity, purity and storage conditions.
It is the buyer's responsibility to ensure their intended research is conducted in compliance with all applicable local, national and international laws — including any ethical-review requirements where animal models are involved.
Language & description guidelines
Because these are research compounds rather than medicines, we do not — and ask researchers not to — describe them in clinical or therapeutic terms. The table below summarises the language we use across product pages, the research blog and the laboratory resources hub.
Compounds covered by this policy
All products in the Wild Ginger Peptides catalogue are supplied under this research-only model. Common compounds:
Related research resources
Read alongside our compliance policy:
Compliance question for a specific research project? support@wgpeptides.uk